DENALI ONCOLOGY GROUP is a USA domiciled entity or foreign entity operating in the USA. The EIN ihas been issued by the IRS
2021-12-31 |
---|
Gross receipts from all sources | USD $ 24,912 |
Net assets / fund balances at end of fiscal year | USD $ 381,330 |
Net assets / fund balances at beginning of fiscal year | USD $ 399,469 |
Contributions, Grants, Gifts etc from current year | USD $ 24,912 |
Total revenue | USD $ 24,912 |
Fees and other payments to independent contractors | USD $ 1,875 |
Total of all other expenses | USD $ 41,176 |
Total of all expenses | USD $ 43,051 |
Net assets or fund balances at end of year | USD $ -18,139 |
2020-12-31 |
---|
Gross receipts from all sources | USD $ 44,375 |
Net assets / fund balances at end of fiscal year | USD $ 399,469 |
Net assets / fund balances at beginning of fiscal year | USD $ 369,589 |
Contributions, Grants, Gifts etc from current year | USD $ 44,375 |
Total revenue | USD $ 44,375 |
Fees and other payments to independent contractors | USD $ 2,829 |
Total of all other expenses | USD $ 11,666 |
Total of all expenses | USD $ 14,495 |
Net assets or fund balances at end of year | USD $ 29,880 |
The following addresses have been detected as associated with Tax Indentification Number 260900479